ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,000 | +33.3% | 449 | -2.8% | 0.00% | – |
| Q2 2018 | $6,000 | +20.0% | 462 | -76.9% | 0.00% | – |
| Q1 2017 | $5,000 | -16.7% | 2,002 | -9.7% | 0.00% | – |
| Q4 2016 | $6,000 | +500.0% | 2,217 | +440.7% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 410 | -30.7% | 0.00% | – |
| Q2 2016 | $2,000 | -66.7% | 592 | -32.0% | 0.00% | – |
| Q2 2014 | $6,000 | -57.1% | 870 | +45.0% | 0.00% | – |
| Q1 2014 | $14,000 | -97.1% | 600 | -98.4% | 0.00% | -100.0% |
| Q2 2013 | $485,000 | – | 36,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |